Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Weight Loss and Supplements Method-and-composition-for-determining-antimicrobial-susceptibility-of-the-majority-clinically-significant-Gram-postitive-organism

 Use of 25-hydroxycholecalciferol in a dietary supplement process for ameliorating the effects of tibial dyschondroplasia in poultry while maintaining weight gain
OF THE INVENTION The present invention relates to a process for ameliorating the effects of; i.e., ...


 Zeaxanthin formulations for human ingestion
This invention discloses zeaxanthin preparations which contain the 3R-3'R stereoisomer of ...


 Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion
This invention discloses a method of making a preparation of zeaxanthin which contains the 3R-3'R ...


 Low phosphorus animal feed containing 1.alpha.-hydroxylated vitamin D compounds and method of preparing
OF THE PREFERRED EMBODIMENT As used in the description and in the claims, the term hydroxy-...


 Polynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a beta-C-4-oxygenase activity for biotechnological production of (3S, 3'S) astaxanthin and its specific expression in chromoplasts of higher plants
It is a general object of this invention to provide a biotechnological method for production of (3S,...


 DNA strands useful for the synthesis of xanthophylls and the process for producing the xanthophylls
What is claimed is: 1. A method for producing a xanthophyll comprising: (a) introducing a DNA ...


 Isolation and formulations of nutrient-rich carotenoids
OF THE INVENTION A principal object of the present invention is to provide a pharmacologically and ...


 Copolymers of flavanoid tannins and acrylic monomers
OF THE PREFERRED EMBODIMENTS By suitable choice of tannins and comonomers, a wide variety of ...


 Method of controlling release of antimicrobial agents in chewing gum
OF THE PREFERRED EMBODIMENTS In the context of this invention, chewing gum refers to chewing gum, ...


 Fatigue recovery medicine for changing in hepatic mRNA levels of stress-related genes
Accordingly, an object of the present invention is to solve the foregoing problems by providing a ...


 Method and composition for determining antimicrobial susceptibility of the majority clinically significant Gram postitive organism

Details
Inventors: Badal, Robert; Kelley, Roger; Sand, Theodore T.; Bascomb, Shoshana;
Assignee: MicroScan, Inc. (West Sacramento, CA)
Primary Examiner: Beisner; William H.
Assistant Examiner: Williams; Jane
Attorney, Agent or Firm: Tymeson; Cynthia G., Winston; Lois K., Buonaiuto; Mark J.

This invention relates to a method to determine susceptibility to antimicrobial agents of a majority of clinically significant Gram positive organisms. This invention also relates to a mixture of fluorogenic substrates used to detect the growth of Gram positive bacteria.

DETAILED DESCRIPTION The invention combines three fluorogenic compounds to facilitate the detection of growth of the majority of clinically significant Gram positive organisms, staphylococci, streptococci, enterococci, and listeriae from between about 31/2-15 hours.
The combination of the three compounds is added to the growth control and to every concentration of the antimicrobial agents compartments.
Growth of the organism is detected by an increase in fluorescence units.
As the organism grows, enzymes are produced which hydrolyze the fluorogenic compound(s), thus releasing the fluorophore, which, when excited by light in the 340-370 nm range, fluoresces in the 440-470 nm range.
If the organism does not grow, the fluorophore part is not released from the compound, and there is no increase in fluorescence at the selected wavelength.
After the organism has grown for between 31/2-15 hour, the amount of fluorescence in the individual concentrations of the antimicrobial agents can be compared to the amount of fluorescence in the growth control, and the minimal inhibitory concentrations of each antimicrobial agent can be determined.
The advantage of utilizing a combination of fluorogenic compounds to detect growth, is the rapidity with which growth and consequently minimal inhibitory concentrations can be determined.
Conventional minimal inhibitory concentration determinations, which rely on turbidity, require 15-24 hours of incubation prior to reading.
Using a combination of certain compounds allows one to determine minimum inhibitory concentrations for the majority of Gram positive organisms, however, within 31/2-15 hours.
Several combinations of fluorogenic compounds were tested and this combination detected growth of most species of Gram positive organisms.
The compounds are leucine-7-amido-4-methylcoumarin, phenylalanine-7-amido-4-methylcoumarin, and 4-methylumbelliferyl phosphate.
This combination detected the majority of clinically relevant species of staphylococci, streptococci, enterococci, and listeriae



Related patents
  Bicyclic carbohydrates as antiviral bioactives for the treatment of infections caused by the alphaherpesvirinae HSV-1 and HSV-2
The invention consists of the novel bicyclic carbohydrate the structure of which is illustrated in FIG. 1 and which is identified herein as Formula A. Compounds of F...
  Cosmetic skin or hair care compositions containing fluorocarbons infused with carbon dioxide
OF THE INVENTION Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of ...
  Pearlescent cosmetic preparations containing dialkyl ethers, silicone compounds and emulsifier
What is claimed is: 1. A pearlescent composition comprising: (a) from about 1 to 15% by weight of a dialkyl ether corresponding to formula (I): R.sup.1 --O--R.sup.2 ...
  Aqueous alcoholic antiperspirant composition containing calcium enhanced antiperspirant salt
OF THE INVENTION The antiperspirant composition of the present invention is in the form of an aqueous alcoholic liquid solution. The composition will generally comprise,...
  Topical treatment of diseased skin disorders
The embodiments of the invention in which an exclusive property or privilege is claimed are as follow: 1. A preparation which is compatible with the skin for the ...
  Method and composition for treatment of diabetes
I claim: 1. A medicinal composition comprising between about 0.5 grams and about 2.0 grams of (-)epicatechin and between about 0.5 and about 2.0 grams of gymnemic acid. 2...
  Process for preparing fat-soluble vitamin active beadlets
OF THE INVENTION The present invention relates to a vitamin-active preparation in the form of a water insoluble beadlet comprising the steps of forming an emulsion ...
  Method for making vitamin enriched cereal
OF THE INVENTION The present invention relates to R-T-E cooked cereal dough products fortified with beta carotene that exhibit unexpected vitamin efficacy stability. In ...
  Zeaxanthin-containing compositions produced by flavobacterium multivorum
I claim: 1. A feed additive comprising a zeaxanthin-containing composition made by culturing a strain of pigmented Flavobacterium multivorum in a nutrient medium that ...
  Enhanced carotenoid accumulation in storage organs of genetically engineered plants
The present invention relates to higher plants transformed to contain a heterologous genomic DNA that encodes a non-higher plant phytoene synthase linked to a plastid ...

0.034

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved